surmount-1 tirzepatide weight loss non-diabetic once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Efficacy and Safety of Tirzepatide

The team, from Peking University Peoples Hospital in China, found that most began to regain weight within about two months of stopping treatment

Thyroid Monitoring: If you are also taking levothyroxine, your doctor may need to check your thyroid levels regularly

MT-I is ontworpen voor gebruik in wetenschappelijke onderzoeken en wordt vaak toegepast in studies die gericht zijn op de mechanismen van pigmentatie en bescherming tegen UV-straling

Mar 1 2010;4(2):359-64

For patients specifically seeking approved weight loss medication, Eli Lilly offers Zepbound (also tirzepatide) which has FDA approval for weight management